BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND KMT2C, ENSG00000055609, MLL3, 58508 AND Treatment
9 results:

  • 1. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
    Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
    Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
    Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
    Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
    Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. kmt2c is a Potential Biomarker of Anti-PD-1 treatment Response in Metastatic Melanoma.
    Xie K; Peng Y; Zhong W; Liu X
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):103. PubMed ID: 35345335
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma.
    Goh AY; Ramlogan-Steel CA; Jenkins KS; Steel JC; Layton CJ
    Neoplasma; 2020 Sep; 67(5):958-971. PubMed ID: 32305056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
    Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
    Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma.
    Weyand AC; Mody RJ; Rabah RM; Opipari VP
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675691
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.
    Pérez-Alea M; Vivancos A; Caratú G; Matito J; Ferrer B; Hernandez-Losa J; Cortés J; Muñoz E; Garcia-Patos V; Recio JA
    Oncotarget; 2016 May; 7(19):28086-95. PubMed ID: 27057633
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.